These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 149590)
1. Susceptibilities of normal and malignant human lung cells in culture to the cytocidal action of antitumor agents. Tsukeda H; Mizuno S; Nitta K Cancer Res; 1978 Aug; 38(8):2529-32. PubMed ID: 149590 [TBL] [Abstract][Full Text] [Related]
2. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. Giaccone G; Gazdar AF; Beck H; Zunino F; Capranico G Cancer Res; 1992 Apr; 52(7):1666-74. PubMed ID: 1312895 [TBL] [Abstract][Full Text] [Related]
3. Differential sensitivities of five rat hepatoma cell lines to anticancer drugs. Barranco SC; Haenelt BR; Gee EL Cancer Res; 1978 Mar; 38(3):656-60. PubMed ID: 75057 [TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines. Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873 [TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice. Geiger T; Müller M; Monia BP; Fabbro D Clin Cancer Res; 1997 Jul; 3(7):1179-85. PubMed ID: 9815797 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of lonidamine alone and in combination with other drugs against murine RIF-1 and human HT1080 cells in vitro. Ning SC; Hahn GM Cancer Res; 1990 Dec; 50(24):7867-70. PubMed ID: 2253227 [TBL] [Abstract][Full Text] [Related]
7. Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor. Nakagawa M; Yamaguchi T; Fukawa H; Ogata J; Komiyama S; Akiyama S; Kuwano M Jpn J Cancer Res; 1985 Apr; 76(4):315-20. PubMed ID: 2408954 [TBL] [Abstract][Full Text] [Related]
8. Drug-induced DNA hypermethylation and drug resistance in human tumors. Nyce J Cancer Res; 1989 Nov; 49(21):5829-36. PubMed ID: 2790794 [TBL] [Abstract][Full Text] [Related]
9. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies. Mekras JA; Boothman DA; Perez LM; Greer S Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164 [TBL] [Abstract][Full Text] [Related]
10. [Current results and perspectives of the use of human tumor cell lines for antitumor drug screening]. Zhukova OS; Dobrynin IaV Vopr Onkol; 2001; 47(6):706-9. PubMed ID: 11826493 [TBL] [Abstract][Full Text] [Related]
11. Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells. Drewinko B; Patchen M; Yang LY; Barlogie B Cancer Res; 1981 Jun; 41(6):2328-33. PubMed ID: 7237431 [TBL] [Abstract][Full Text] [Related]
12. Effect of melatonin on cytotoxicity of doxorubicin toward selected cell lines (human keratinocytes, lung cancer cell line A-549, laryngeal cancer cell line Hep-2). Fic M; Podhorska-Okolow M; Dziegiel P; Gebarowska E; Wysocka T; Drag-Zalesinska M; Zabel M In Vivo; 2007; 21(3):513-8. PubMed ID: 17591362 [TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of the differential cytotoxicity of keto-C-glycosides toward normal and malignant cells. Bennani-Baiti IM; Lafarge-Frayssinet C; Herscovici J; Monserret R; Robbana-Barnat S; Antonakis K; Frayssinet C; Uriel J Anticancer Res; 1993; 13(2):467-73. PubMed ID: 8517664 [TBL] [Abstract][Full Text] [Related]
14. An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine. Kiura K; Ohnoshi T; Ueoka H; Takigawa N; Tabata M; Segawa Y; Shibayama T; Kimura I Anticancer Drug Des; 1992 Dec; 7(6):463-70. PubMed ID: 1337430 [TBL] [Abstract][Full Text] [Related]
15. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines. Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096 [TBL] [Abstract][Full Text] [Related]
16. [Update of human tumor clonogenic assay in carcinoma of the lung]. Kanzawa F Gan To Kagaku Ryoho; 1985 Aug; 12(8):1552-9. PubMed ID: 2992395 [TBL] [Abstract][Full Text] [Related]
17. [Sensitivity of antineoplastic agents in squamous cell carcinoma of the uterine cervix xenografted into nude mice]. Kawabata M; Hosokawa H; Katoh K; Izumi R Gan To Kagaku Ryoho; 1987 Nov; 14(11):3058-63. PubMed ID: 2445295 [TBL] [Abstract][Full Text] [Related]
18. In vitro chemosensitivity of human lung cancer cell lines. Ruckdeschel JC; Carney DN; Oie HK; Russell EK; Gazdar AF Cancer Treat Rep; 1987; 71(7-8):697-704. PubMed ID: 3038314 [TBL] [Abstract][Full Text] [Related]
19. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines. Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631 [TBL] [Abstract][Full Text] [Related]
20. Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells. Diasio RB; Schuetz JD; Wallace HJ; Sommadossi JP Cancer Res; 1985 Oct; 45(10):4900-3. PubMed ID: 3928143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]